Search

Your search keyword '"Bhan, Virender"' showing total 159 results

Search Constraints

Start Over You searched for: Author "Bhan, Virender" Remove constraint Author: "Bhan, Virender" Publication Year Range Last 50 years Remove constraint Publication Year Range: Last 50 years
159 results on '"Bhan, Virender"'

Search Results

3. Secondary Progressive Multiple Sclerosis: A Review of Clinical Characteristics, Definition, Prognostic Tools, and Disease-Modifying Therapies

4. Health Canada drug approval process: a barrier to personalized care in multiple sclerosis

5. Natalizumab treatment shows low cumulative probabilities of confirmed disability worsening to EDSS milestones in the long-term setting

6. Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension

7. Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

8. MRI and laboratory features and the performance of international criteria in the diagnosis of multiple sclerosis in children and adolescents: a prospective cohort study

9. Cost–consequence analysis of ofatumumab for the treatment of relapsing-remitting multiple sclerosis in Canada

12. Secondary Progressive Multiple Sclerosis

15. Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: a prospective national cohort study

16. Cost effectiveness of Ofatumumab in Comparison with Other Disease Modifying Therapies and Best Supportive Care for the Treatment of Relapsing-Remitting Multiple Sclerosis in Canada (P1-1.Virtual)

20. Cervical Spinal Cord Atrophy can be Accurately Quantified Using Head Images

21. Multiple Sclerosis Progression Discussion Tool Usability and Usefulness in Clinical Practice: Cross-sectional, Web-Based Survey

22. Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Positive Patients in a Multi-Ethnic Canadian Cohort.

23. Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study

24. Multiple Sclerosis Progression Discussion Tool: Usability and Usefulness in Clinical Practice (Preprint)

25. Development and Usability Testing of a Patient-based Digital Tool to Understand Early Signs of Changes in Multiple Sclerosis Symptoms and Progression: Your MS Questionnaire (2118)

26. Genetic susceptibility to MS: a second stage analysis in Canadian MS families

27. Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Positive Patients in a Multi-Ethnic Canadian Cohort

28. Associations Between Findings From Myelin Water Imaging and Cognitive Performance Among Individuals With Multiple Sclerosis

29. Myelin Damage in Normal Appearing White Matter Contributes to Impaired Cognitive Processing Speed in Multiple Sclerosis

31. Natalizumab treatment shows low cumulative probabilities of confirmed disability worsening to EDSS milestones in the long-term setting

32. Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension

33. Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

34. MRI and laboratory features and the performance of international criteria in the diagnosis of multiple sclerosis in children and adolescents: a prospective cohort study

35. Trial of Minocycline in a Clinically Isolated Syndrome of Multiple Sclerosis

36. Myelin Damage in Normal Appearing White Matter Contributes to Impaired Cognitive Processing Speed in Multiple Sclerosis.

41. Evolving role of MRI in optimizing the treatment of multiple sclerosis: Canadian Consensus recommendations

44. Randomized Trial of Minocycline for Clinically Isolated Syndrome and Early Single Relapse Multiple Sclerosis: Study Design, Participant Characteristics, and Recruitment Challenges (P1.227)

48. Temporal changes in age at onset of multiple sclerosis: Importance of controlling for equal observation time.

Catalog

Books, media, physical & digital resources